Prediction of blood–brain barrier permeation in drug discovery from in vivo, in vitro and in silico models

Abbott, 1996, Transporting therapeutics across the blood–brain barrier, Mol. Med. Today, 2, 106, 10.1016/1357-4310(96)88720-X Begley, 2003, Structural and functional aspects of the blood–brain barrier, 39 Abbott, 2004, Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology, Neurochem. Int., 45, 545, 10.1016/j.neuint.2003.11.006 Bodor, 2003, Brain-targeted drug delivery – experiences to date, Am. J. Drug Deliv., 1, 13, 10.2165/00137696-200301010-00002 Begley, 2004, Efflux mechanisms in the central nervous system: a powerful influence on drug distribution within the brain, 83 Pardridge, 2003, Blood–brain barrier drug targeting: the future of brain drug development, Mol. Intervent., 3, 90, 10.1124/mi.3.2.90 Abbott, 2002, Astrocyte–endothelial interactions and blood–brain barrier permeability, J. Anat., 200, 629, 10.1046/j.1469-7580.2002.00064.x Feng, 2002, Assessment of blood–brain barrier penetration: in silico, in vitro and in vivo, Curr. Drug Metab., 3, 647, 10.2174/1389200023337063 Smith, 2003, A review of blood–brain barrier transport techniques, 193 Hansen, 2002, Comparison of in vitro BBMEC permeability and in vivo CNS uptake by microdialysis sampling, J. Pharm. Biomed. Anal., 27, 945, 10.1016/S0731-7085(01)00542-8 Dai, 2003, Drug transport studies using quantitative microdialysis, 249 Atkinson, 2002, Lipophilicity and other parameters affecting brain penetration, Curr. Med. Chem., 2, 229 Schinkel, 1999, P-glycoprotein, a gatekeeper in the blood–brain barrier, Adv. Drug. Del. Rev., 36, 179, 10.1016/S0169-409X(98)00085-4 Cisternino, 2004, Expression, up-regulation, and transport activity of the multidrug-resistance protein ABCG2 at the mouse blood–brain barrier, Cancer Res., 64, 3296, 10.1158/0008-5472.CAN-03-2033 Sisodiya, 2003, Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy, Epilepsia, 44, 1388, 10.1046/j.1528-1157.2003.21803.x Gumbleton, 2001, Progress and limitations in the use of in vitro cell cultures to serve as permeability screen for the blood–brain barrier, J. Pharm. Sci., 90, 1681, 10.1002/jps.1119 Reichel, 2003, An overview of in vitro techniques for blood–brain barrier studies, 307 Franke, 2000, Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood–brain barrier in vitro, Brain Res. Protocols, 5, 248, 10.1016/S1385-299X(00)00020-9 Prieto, 2004, Blood–brain barrier in vitro models and their application in toxicology, ATLA, 32, 37 Dehouck, 1990, An easier, reproducible, and mass-production method to study the blood–brain barrier in vitro, J. Neurochem., 54, 1798, 10.1111/j.1471-4159.1990.tb01236.x Török, 2003, Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions, Exp. Brain Res., 153, 356, 10.1007/s00221-003-1620-4 Lundquist, 2002, Prediction of drug transport through the blood–brain barrier in vivo: a comparison between two in vitro models, Pharm. Res., 19, 976, 10.1023/A:1016462205267 Toimela, 2004, Development of an in vitro blood–brain barrier model – cytotoxicity of mercury and aluminium, Toxicol. Appl. Pharmacol., 195, 73, 10.1016/j.taap.2003.11.002 Lauer, 2004, Development of an in vitro blood–brain barrier model based on immortalized porcine brain microvascular endothelial cells, Il Farmaco, 59, 133, 10.1016/j.farmac.2003.11.007 Terasaki, 2003, New approaches to in vitro models of blood–brain barrier drug transport, Drug Discov. Today, 8, 944, 10.1016/S1359-6446(03)02858-7 Stanness, 1997, Morphological and functional characterization of an in vitro blood–brain barrier model, Brain Res., 771, 329, 10.1016/S0006-8993(97)00829-9 Cucullo, 2002, A new dynamic in vitro model for the multidimensional study of astrocyte–endothelial cell interactions at the blood–brain barrier, Brain Res., 951, 243, 10.1016/S0006-8993(02)03167-0 Dehouck, 2002, In vitro blood–brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions, Brain Res., 955, 229, 10.1016/S0006-8993(02)03469-8 Fricker, 2002, Permeability of porcine blood brain barrier to somatostatin analogues, Br. J. Pharmacol., 135, 1308, 10.1038/sj.bjp.0704557 Lohmann, 2002, Predicting blood–brain barrier permeability of drugs: evaluation of different in vitro assays, J. Drug Target, 10, 263, 10.1080/10611860290031903 Reichel, 1998, Potential of immobilized artificial membranes for predicting dug penetration across the blood–brain barrier, Pharm. Res., 15, 1270, 10.1023/A:1011904311149 Di, 2003, High throughput artificial membrane permeability assay for blood–brain barrier, Eur. J. Med. Chem., 38, 223, 10.1016/S0223-5234(03)00012-6 Rose, 2002, Modelling blood–brain barrier partitioning using the electrotopological state, J. Chem. Inf. Comput. Sci., 42, 651, 10.1021/ci010127n Sippl, 2002, Computational approaches for the prediction of blood–brain barrier permeation, Curr. Med. Chem., 2, 211 Van de Waterbeemd, 1998, Estimation of blood–brain barrier crossing of dugs using molecular size and shape, and H-bonding descriptors, J. Drug Target, 6, 151, 10.3109/10611869808997889 Clark, 2003, In silico prediction of blood–brain barrier permeation, Drug Discov. Today, 8, 927, 10.1016/S1359-6446(03)02827-7 Kelder, 1999, Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs, Pharm. Res., 16, 1514, 10.1023/A:1015040217741 Abraham, 2002, Application of hydrogen bonding calculations in property based drug design, Drug Discov. Today, 7, 1056, 10.1016/S1359-6446(02)02478-9 Plats, 2001, Correlation and prediction of a large blood–brain distribution data set – an LFER study, Eur. J. Med. Chem., 36, 719, 10.1016/S0223-5234(01)01269-7 Gratton, 1997, Molecular factors influencing drug transfer across the blood–brain barrier, J. Pharm. Pharmacol., 49, 1211, 10.1111/j.2042-7158.1997.tb06072.x Didziapetris, 2003, Classification analysis of P-glycoprotein substrate specificity, J. Drug Target, 11, 391, 10.1080/10611860310001648248 Usansky, 2003, Computation of logBB values for compounds transported through carrier-mediated mechanisms using in vitro permeability data from brain microvessel endothelial cells (BMEC) monolayers, Pharm. Res., 20, 390, 10.1023/A:1022647903205